Concepedia

Publication | Closed Access

Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL

DOI

53

Citations

19

References

2023

Year

Angus Hodder, Avijeet Kumar Mishra, Amir Enshaei, Susan Baird, Kaljit Bhuller, Ismail Elbeshlawi, Denise Bonney, Katherine Clesham, Michelle Cummins, Aditi Vedi,
Journal of Clinical Oncology

Abstract

Blina is safe and effective in first-line treatment of chemotherapy-intolerant CYP with ALL.

References

YearCitations

Page 1